Squarepoint
BHVN

Squarepoint’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Squarepoint’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,230
Closed -$1.49M – 3670
2022
Q2 		$1.49M Sell
10,230
-1,443
-12% -$184K 0.01% 1365
2022
Q1 		$1.38M Buy
+11,673
New +$1.46M 0.01% 1386
2021
Q4 		– Sell
-12,927
Closed -$1.8M – 3707
2021
Q3 		$1.8M Buy
12,927
+7,486
+138% +$935K 0.01% 1257
2021
Q2 		$528K Buy
+5,441
New +$442K ﹤0.01% 2088
2020
Q4 		– Sell
-13,774
Closed -$895K – 3475
2020
Q3 		$895K Buy
+13,774
New +$903K 0.01% 1058
2020
Q2 		– Sell
-20,213
Closed -$688K – 2699
2020
Q1 		$688K Sell
20,213
-18,016
-47% -$824K 0.02% 884
2019
Q4 		$2.08M Buy
38,229
+8,917
+30% +$442K 0.01% 883
2019
Q3 		$1.22M Sell
29,312
-31,512
-52% -$1.33M 0.01% 1089
2019
Q2 		$2.66M Sell
60,824
-20,577
-25% -$1.16M 0.03% 699
2019
Q1 		$4.19M Buy
81,401
+25,800
+46% +$1.11M 0.04% 511
2018
Q4 		$2.06M Buy
55,601
+745
+1% +$26.9K 0.02% 669
2018
Q3 		$2.06M Buy
54,856
+40,256
+276% +$1.48M 0.02% 720
2018
Q2 		$577K Buy
14,600
+4,500
+45% +$143K 0.01% 1121
2018
Q1 		$260K Sell
10,100
-11,465
-53% -$343K ﹤0.01% 1384
2017
Q4 		$582K Buy
+21,565
New +$594K 0.01% 1115

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Squarepoint's BHVN Position: Q3 2022 in Review

Squarepoint sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 10,230 shares — an estimated $1.49M sold.

Squarepoint first reported a position in BHVN in Q4 2017 and held it in 15 quarters. The position peaked at $4.19M in Q1 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Squarepoint reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 10,230 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $1.49M.
  • Squarepoint first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 15 quarters.
  • Squarepoint's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.19M in Q1 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.